{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:24:50Z","timestamp":1779294290107,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":3747,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1111\/j.1600-6143.2012.04124.x","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T22:43:22Z","timestamp":1339195402000},"page":"2546-2553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Antibody Mediated Rejection Associated With Complement Factor H\u2013Related Protein 3\/1 Deficiency Successfully Treated With Eculizumab"],"prefix":"10.1016","volume":"12","author":[{"given":"D.","family":"Noone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Al-Matrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tinckam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Herzenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.","family":"Thorner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.G.","family":"Pluthero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.A.","family":"Kahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Filler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Licht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2012.04124.x_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14656566.2011.525219","article-title":"Antibody-mediated rejection in kidney transplantation: An update","volume":"12","author":"Lucas","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/ndt\/gfp610","article-title":"The histological development of acute antibody-mediated rejection in HLA antibody-incompatible renal transplantation","volume":"25","author":"Higgins","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.beha.2009.07.004","article-title":"Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies","volume":"22","author":"Moake","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2215\/CJN.05870710","article-title":"Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies","volume":"6","author":"Meehan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.smim.2011.08.015","article-title":"Treatment options and strategies for antibody mediated rejection after renal transplantation","volume":"24","author":"Levine","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5-C5a receptor axis","volume":"48","author":"Woodruff","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0609.2011.01701.x","article-title":"Treatment of paroxysmal nocturnal Hemoglobinuria in the era of eculizumab","volume":"87","author":"Roth","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib9","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01090209","article-title":"Complement inhibitor eculizumab in atypical hemolytic uremic syndrome","volume":"4","author":"Mache","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib11","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib12","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib13","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib14","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J Med Genet"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3182145306","article-title":"Novel strategies in immunosuppression: Issues in perspective","volume":"91","author":"Webber","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib20","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/TP.0b013e318230c0bd","article-title":"Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab","volume":"92","author":"Wilson","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.transproceed.2011.02.064","article-title":"Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation\u2014a case report","volume":"43","author":"Chandran","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib22","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1600-6143.2011.03646.x","article-title":"Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates","volume":"11","author":"Chen Song","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: Functional roles, genetic variations and disease associations","volume":"41","author":"Rodriguez de Cordoba","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib24","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","article-title":"An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)","volume":"19","author":"Fritsche","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1172\/JCI108689","article-title":"Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation","volume":"59","author":"Sissons","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib28","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib29","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib30","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-010-1446-9","article-title":"DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome","volume":"25","author":"Zipfel","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib31","doi-asserted-by":"crossref","first-page":"e1002079","DOI":"10.1371\/journal.pgen.1002079","article-title":"Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","article-title":"Genome-wide association study identifies susceptibility loci for IgA nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet"},{"key":"10.1111\/j.1600-6143.2012.04124.x_bib33","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2012.04124.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522276266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522276266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2012.04124.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:57:53Z","timestamp":1761627473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522276266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1600613522276266"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04124.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody Mediated Rejection Associated With Complement Factor H\u2013Related Protein 3\/1 Deficiency Successfully Treated With Eculizumab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04124.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}